Most people don’t die from breast cancer itself — they die when the cancer spreads. Yet metastasis remains one of the least understood and most difficult aspects of the disease to treat.

Making a different requires knowledge, getting experience, disappointment, and then doubling down and going at it again. Many who call themselves advocates don’t do that. I encourage you that if you truly want to make a difference; learn, invest your time as well as your money, and be patient. Do not merely yell loudly for your cause.

I argue that there is different, bureaucratic golden rule at play– the guy with the gold makes up the rules. Those with the power to dole out funds can influence and achieve their intended goals through the scoring criteria they use to evaluative proposals, who they place on the review section panels and who they chose to use. Through these mechanisms, they could (and perhaps do) influence what and who gets selected.

Research dollars matter most when they target questions, not just causes.

Progress comes when we stop driving down the middle and start finding the edge.

Convergent research advances science — convergent thinking can stall it.

Healthcare costs aren’t mysterious — they’re the product of design, incentives, and engagement.

Power abroad begins with stability at home — context decides credibility.

Just like racing, in my cancer world, I need to get the research car in the best position possible before I turn it over to the closing driver – maybe that’s NIH, a drug company, or someone else. But we have to build momentum if we want a chance to win. That’s why I’m working and investing in the early stages of the research race.

Only focusing on one or two legs doesn’t get us where we need to be as fast as needed. This is kind of how cancer treatment development and research works. Think of it like a cancer relay race.

Be cautious if reading or listening to news from international outlets, understand the rules they are playing by.

If you’re doing business in another county, you need to understand the rules and comply.

Foundation does things differently, and after 10+ years of making contributions, I know our process works. Let me share how you can maximize your contribution dollars.

In this episode, Macklin and Giovanis discuss the power of math and collaboration in cancer research.

A promising study shows that certain may more safely help detect and treat cancer. Researchers tested several types of tiny iron oxide particles—similar to those already approved by the FDA for other uses—to see how they affect the body and where they travel after injection.

2025 Symposium: Improving Breast Cancer Outcomes // Revealing and Targeting Immune Interaction

JKTG-funded project aims to answer question: Why do cancer cells selectively colonize in the liver?

In the new episode of Driving Research, Ted talks with Dr. Laura Heiser (OHSU) about treating the toughest cancers—and how teaming up with JKTG brought unexpected lessons, in and out of the lab.

How many legs does a dog have if you call a tail a leg? Still four. Saying it doesn't make it true. To get to the “truth” we need to filter out things that could alter our perception.

New project reflects JKTG focus on building collaborative research to fast-track cancer breakthroughs